These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32133396)

  • 1. Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of
    Foulon M; Pouchin A; Manry J; Khater F; Robbe-Saule M; Durand A; Esnault L; Delneste Y; Jeannin P; Saint-André JP; Croué A; Altare F; Abel L; Alcaïs A; Marion E
    Sci Adv; 2020 Feb; 6(9):eaax7781. PubMed ID: 32133396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H; Coutanceau E; Leclerc M; Caleechurn L; Leadlay PF; Demangel C
    PLoS Negl Trop Dis; 2008; 2(10):e325. PubMed ID: 18941518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.
    Marion E; Jarry U; Cano C; Savary C; Beauvillain C; Robbe-Saule M; Preisser L; Altare F; Delneste Y; Jeannin P; Marsollier L
    J Immunol; 2016 Mar; 196(6):2690-8. PubMed ID: 26873988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buruli ulcer.
    Einarsdottir T; Huygen K
    Hum Vaccin; 2011 Nov; 7(11):1198-203. PubMed ID: 22048117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.
    Demangel C; Stinear TP; Cole ST
    Nat Rev Microbiol; 2009 Jan; 7(1):50-60. PubMed ID: 19079352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional adaptation of
    Robbe-Saule M; Foulon M; Poncin I; Esnault L; Varet H; Legendre R; Besnard A; Grzegorzewicz AE; Jackson M; Canaan S; Marsollier L; Marion E
    Virulence; 2021 Dec; 12(1):1438-1451. PubMed ID: 34107844
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.
    Bolz M; Bénard A; Dreyer AM; Kerber S; Vettiger A; Oehlmann W; Singh M; Duthie MS; Pluschke G
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004431. PubMed ID: 26849213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer.
    Hall B; Simmonds R
    Biochem Soc Trans; 2014 Feb; 42(1):177-83. PubMed ID: 24450648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
    Silva MT; Portaels F; Pedrosa J
    Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry of mycolactones, the causative toxins of Buruli ulcer.
    Kishi Y
    Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6703-8. PubMed ID: 21383136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.
    Bolz M; Ruggli N; Borel N; Pluschke G; Ruf MT
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004678. PubMed ID: 27128097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease.
    Phillips R; Sarfo FS; Guenin-Macé L; Decalf J; Wansbrough-Jones M; Albert ML; Demangel C
    J Infect Dis; 2009 Dec; 200(11):1675-84. PubMed ID: 19863437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycolactone gene expression is controlled by strong SigA-like promoters with utility in studies of Mycobacterium ulcerans and buruli ulcer.
    Tobias NJ; Seemann T; Pidot SJ; Porter JL; Marsollier L; Marion E; Letournel F; Zakir T; Azuolas J; Wallace JR; Hong H; Davies JK; Howden BP; Johnson PD; Jenkin GA; Stinear TP
    PLoS Negl Trop Dis; 2009 Nov; 3(11):e553. PubMed ID: 19936295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview: Mycolactone , the Macrolide Toxin of Mycobacterium ulcerans.
    Röltgen K; Pluschke G
    Methods Mol Biol; 2022; 2387():105-108. PubMed ID: 34643906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection.
    Walsh DS; Portaels F; Meyers WM
    Dermatol Clin; 2011 Jan; 29(1):1-8. PubMed ID: 21095521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.
    Sarfo FS; Phillips R; Wansbrough-Jones M; Simmonds RE
    Cell Microbiol; 2016 Jan; 18(1):17-29. PubMed ID: 26572803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buruli ulcer: emerging from obscurity.
    Wansbrough-Jones M; Phillips R
    Lancet; 2006 Jun; 367(9525):1849-58. PubMed ID: 16753488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
    Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.
    Fraga AG; Cruz A; Martins TG; Torrado E; Saraiva M; Pereira DR; Meyers WM; Portaels F; Silva MT; Castro AG; Pedrosa J
    Infect Immun; 2011 Jan; 79(1):421-30. PubMed ID: 20974825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycolactone cytotoxicity in Schwann cells could explain nerve damage in Buruli ulcer.
    En J; Kitamoto S; Kawashima A; Yonezawa S; Kishi Y; Ishii N; Goto M
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005834. PubMed ID: 28783752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.